nodes	percent_of_prediction	percent_of_DWPC	metapath
Fulvestrant—ESRRA—Tamoxifen—pancreatic cancer	0.474	0.651	CbGbCtD
Fulvestrant—ESR2—Tamoxifen—pancreatic cancer	0.147	0.201	CbGbCtD
Fulvestrant—ESR1—Tamoxifen—pancreatic cancer	0.0751	0.103	CbGbCtD
Fulvestrant—NR1H4—bile duct—pancreatic cancer	0.0308	0.418	CbGeAlD
Fulvestrant—NR1H4—bile—pancreatic cancer	0.0237	0.321	CbGeAlD
Fulvestrant—CYP3A4—Tamoxifen—pancreatic cancer	0.00772	0.0106	CbGbCtD
Fulvestrant—NR1H4—gall bladder—pancreatic cancer	0.00657	0.0892	CbGeAlD
Fulvestrant—CYP3A4—Erlotinib—pancreatic cancer	0.00656	0.00901	CbGbCtD
Fulvestrant—CYP3A4—Irinotecan—pancreatic cancer	0.00593	0.00814	CbGbCtD
Fulvestrant—CYP3A4—Docetaxel—pancreatic cancer	0.00434	0.00596	CbGbCtD
Fulvestrant—CYP3A4—Sunitinib—pancreatic cancer	0.00432	0.00594	CbGbCtD
Fulvestrant—ESRRA—islet of Langerhans—pancreatic cancer	0.0033	0.0448	CbGeAlD
Fulvestrant—CYP3A4—Doxorubicin—pancreatic cancer	0.00324	0.00445	CbGbCtD
Fulvestrant—NR1H4—digestive system—pancreatic cancer	0.00258	0.0351	CbGeAlD
Fulvestrant—ESRRA—pancreas—pancreatic cancer	0.00232	0.0315	CbGeAlD
Fulvestrant—ESRRA—digestive system—pancreatic cancer	0.00198	0.0269	CbGeAlD
Fulvestrant—ESR2—digestive system—pancreatic cancer	0.00119	0.0161	CbGeAlD
Fulvestrant—ESR1—digestive system—pancreatic cancer	0.000813	0.011	CbGeAlD
Fulvestrant—CYP3A4—digestive system—pancreatic cancer	0.000454	0.00616	CbGeAlD
Fulvestrant—Hepatitis—Docetaxel—pancreatic cancer	0.00021	0.00157	CcSEcCtD
Fulvestrant—Diarrhoea—Tamoxifen—pancreatic cancer	0.000209	0.00156	CcSEcCtD
Fulvestrant—Infection—Gemcitabine—pancreatic cancer	0.000208	0.00156	CcSEcCtD
Fulvestrant—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000208	0.00156	CcSEcCtD
Fulvestrant—Pharyngitis—Docetaxel—pancreatic cancer	0.000208	0.00156	CcSEcCtD
Fulvestrant—Abdominal pain—Sunitinib—pancreatic cancer	0.000207	0.00155	CcSEcCtD
Fulvestrant—Body temperature increased—Sunitinib—pancreatic cancer	0.000207	0.00155	CcSEcCtD
Fulvestrant—Diarrhoea—Erlotinib—pancreatic cancer	0.000207	0.00155	CcSEcCtD
Fulvestrant—Oedema peripheral—Docetaxel—pancreatic cancer	0.000206	0.00155	CcSEcCtD
Fulvestrant—Connective tissue disorder—Docetaxel—pancreatic cancer	0.000206	0.00154	CcSEcCtD
Fulvestrant—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000206	0.00154	CcSEcCtD
Fulvestrant—Anorexia—Irinotecan—pancreatic cancer	0.000205	0.00154	CcSEcCtD
Fulvestrant—Infection—Fluorouracil—pancreatic cancer	0.000205	0.00153	CcSEcCtD
Fulvestrant—Pain in extremity—Epirubicin—pancreatic cancer	0.000204	0.00153	CcSEcCtD
Fulvestrant—Skin disorder—Gemcitabine—pancreatic cancer	0.000204	0.00153	CcSEcCtD
Fulvestrant—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000203	0.00152	CcSEcCtD
Fulvestrant—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000202	0.00152	CcSEcCtD
Fulvestrant—Hot flush—Doxorubicin—pancreatic cancer	0.000202	0.00151	CcSEcCtD
Fulvestrant—Dizziness—Tamoxifen—pancreatic cancer	0.000202	0.00151	CcSEcCtD
Fulvestrant—Menopausal symptoms—Doxorubicin—pancreatic cancer	0.0002	0.0015	CcSEcCtD
Fulvestrant—Anorexia—Gemcitabine—pancreatic cancer	0.0002	0.0015	CcSEcCtD
Fulvestrant—Dizziness—Erlotinib—pancreatic cancer	0.0002	0.0015	CcSEcCtD
Fulvestrant—Anorexia—Fluorouracil—pancreatic cancer	0.000197	0.00147	CcSEcCtD
Fulvestrant—Insomnia—Irinotecan—pancreatic cancer	0.000195	0.00146	CcSEcCtD
Fulvestrant—Vomiting—Tamoxifen—pancreatic cancer	0.000194	0.00145	CcSEcCtD
Fulvestrant—Paraesthesia—Irinotecan—pancreatic cancer	0.000193	0.00145	CcSEcCtD
Fulvestrant—Hypersensitivity—Sunitinib—pancreatic cancer	0.000193	0.00144	CcSEcCtD
Fulvestrant—Rash—Tamoxifen—pancreatic cancer	0.000192	0.00144	CcSEcCtD
Fulvestrant—Dermatitis—Tamoxifen—pancreatic cancer	0.000192	0.00144	CcSEcCtD
Fulvestrant—Vomiting—Erlotinib—pancreatic cancer	0.000192	0.00144	CcSEcCtD
Fulvestrant—Dyspnoea—Irinotecan—pancreatic cancer	0.000192	0.00144	CcSEcCtD
Fulvestrant—Headache—Tamoxifen—pancreatic cancer	0.000191	0.00143	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000191	0.00143	CcSEcCtD
Fulvestrant—Rash—Erlotinib—pancreatic cancer	0.00019	0.00143	CcSEcCtD
Fulvestrant—Dermatitis—Erlotinib—pancreatic cancer	0.00019	0.00142	CcSEcCtD
Fulvestrant—Angiopathy—Docetaxel—pancreatic cancer	0.00019	0.00142	CcSEcCtD
Fulvestrant—Insomnia—Gemcitabine—pancreatic cancer	0.00019	0.00142	CcSEcCtD
Fulvestrant—Dyspepsia—Irinotecan—pancreatic cancer	0.00019	0.00142	CcSEcCtD
Fulvestrant—Immune system disorder—Docetaxel—pancreatic cancer	0.000189	0.00142	CcSEcCtD
Fulvestrant—Headache—Erlotinib—pancreatic cancer	0.000189	0.00142	CcSEcCtD
Fulvestrant—Pain in extremity—Doxorubicin—pancreatic cancer	0.000189	0.00142	CcSEcCtD
Fulvestrant—Paraesthesia—Gemcitabine—pancreatic cancer	0.000188	0.00141	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000188	0.00141	CcSEcCtD
Fulvestrant—Asthenia—Sunitinib—pancreatic cancer	0.000188	0.0014	CcSEcCtD
Fulvestrant—Decreased appetite—Irinotecan—pancreatic cancer	0.000187	0.0014	CcSEcCtD
Fulvestrant—Dyspnoea—Gemcitabine—pancreatic cancer	0.000187	0.0014	CcSEcCtD
Fulvestrant—Insomnia—Fluorouracil—pancreatic cancer	0.000187	0.0014	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000186	0.00139	CcSEcCtD
Fulvestrant—Fatigue—Irinotecan—pancreatic cancer	0.000186	0.00139	CcSEcCtD
Fulvestrant—Paraesthesia—Fluorouracil—pancreatic cancer	0.000185	0.00139	CcSEcCtD
Fulvestrant—Pruritus—Sunitinib—pancreatic cancer	0.000185	0.00139	CcSEcCtD
Fulvestrant—Breast disorder—Epirubicin—pancreatic cancer	0.000185	0.00138	CcSEcCtD
Fulvestrant—Pain—Irinotecan—pancreatic cancer	0.000184	0.00138	CcSEcCtD
Fulvestrant—Constipation—Irinotecan—pancreatic cancer	0.000184	0.00138	CcSEcCtD
Fulvestrant—Dyspnoea—Fluorouracil—pancreatic cancer	0.000184	0.00138	CcSEcCtD
Fulvestrant—Malnutrition—Docetaxel—pancreatic cancer	0.000182	0.00137	CcSEcCtD
Fulvestrant—Decreased appetite—Gemcitabine—pancreatic cancer	0.000182	0.00137	CcSEcCtD
Fulvestrant—Dyspepsia—Fluorouracil—pancreatic cancer	0.000182	0.00136	CcSEcCtD
Fulvestrant—Nausea—Tamoxifen—pancreatic cancer	0.000181	0.00136	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000181	0.00136	CcSEcCtD
Fulvestrant—Fatigue—Gemcitabine—pancreatic cancer	0.000181	0.00135	CcSEcCtD
Fulvestrant—Pain—Gemcitabine—pancreatic cancer	0.000179	0.00134	CcSEcCtD
Fulvestrant—Constipation—Gemcitabine—pancreatic cancer	0.000179	0.00134	CcSEcCtD
Fulvestrant—Nausea—Erlotinib—pancreatic cancer	0.000179	0.00134	CcSEcCtD
Fulvestrant—Decreased appetite—Fluorouracil—pancreatic cancer	0.000179	0.00134	CcSEcCtD
Fulvestrant—Diarrhoea—Sunitinib—pancreatic cancer	0.000179	0.00134	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000178	0.00133	CcSEcCtD
Fulvestrant—Influenza—Epirubicin—pancreatic cancer	0.000177	0.00132	CcSEcCtD
Fulvestrant—Back pain—Docetaxel—pancreatic cancer	0.000176	0.00132	CcSEcCtD
Fulvestrant—Pain—Fluorouracil—pancreatic cancer	0.000176	0.00132	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000176	0.00132	CcSEcCtD
Fulvestrant—Dizziness—Sunitinib—pancreatic cancer	0.000173	0.00129	CcSEcCtD
Fulvestrant—Breast disorder—Doxorubicin—pancreatic cancer	0.000171	0.00128	CcSEcCtD
Fulvestrant—Body temperature increased—Irinotecan—pancreatic cancer	0.00017	0.00128	CcSEcCtD
Fulvestrant—Abdominal pain—Irinotecan—pancreatic cancer	0.00017	0.00128	CcSEcCtD
Fulvestrant—Anaemia—Docetaxel—pancreatic cancer	0.000169	0.00126	CcSEcCtD
Fulvestrant—Vomiting—Sunitinib—pancreatic cancer	0.000166	0.00125	CcSEcCtD
Fulvestrant—Body temperature increased—Gemcitabine—pancreatic cancer	0.000166	0.00124	CcSEcCtD
Fulvestrant—Rash—Sunitinib—pancreatic cancer	0.000165	0.00123	CcSEcCtD
Fulvestrant—Dermatitis—Sunitinib—pancreatic cancer	0.000165	0.00123	CcSEcCtD
Fulvestrant—Urticaria—Fluorouracil—pancreatic cancer	0.000164	0.00123	CcSEcCtD
Fulvestrant—Headache—Sunitinib—pancreatic cancer	0.000164	0.00123	CcSEcCtD
Fulvestrant—Influenza—Doxorubicin—pancreatic cancer	0.000163	0.00122	CcSEcCtD
Fulvestrant—Leukopenia—Docetaxel—pancreatic cancer	0.000163	0.00122	CcSEcCtD
Fulvestrant—Body temperature increased—Fluorouracil—pancreatic cancer	0.000163	0.00122	CcSEcCtD
Fulvestrant—Cough—Docetaxel—pancreatic cancer	0.000159	0.00119	CcSEcCtD
Fulvestrant—Hypersensitivity—Irinotecan—pancreatic cancer	0.000159	0.00119	CcSEcCtD
Fulvestrant—Infestation NOS—Epirubicin—pancreatic cancer	0.000157	0.00118	CcSEcCtD
Fulvestrant—Infestation—Epirubicin—pancreatic cancer	0.000157	0.00118	CcSEcCtD
Fulvestrant—Arthralgia—Docetaxel—pancreatic cancer	0.000155	0.00116	CcSEcCtD
Fulvestrant—Myalgia—Docetaxel—pancreatic cancer	0.000155	0.00116	CcSEcCtD
Fulvestrant—Chest pain—Docetaxel—pancreatic cancer	0.000155	0.00116	CcSEcCtD
Fulvestrant—Nausea—Sunitinib—pancreatic cancer	0.000155	0.00116	CcSEcCtD
Fulvestrant—Asthenia—Irinotecan—pancreatic cancer	0.000155	0.00116	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000154	0.00116	CcSEcCtD
Fulvestrant—Urinary tract infection—Epirubicin—pancreatic cancer	0.000153	0.00115	CcSEcCtD
Fulvestrant—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000152	0.00114	CcSEcCtD
Fulvestrant—Sweating—Epirubicin—pancreatic cancer	0.000151	0.00113	CcSEcCtD
Fulvestrant—Asthenia—Gemcitabine—pancreatic cancer	0.000151	0.00113	CcSEcCtD
Fulvestrant—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000149	0.00112	CcSEcCtD
Fulvestrant—Pruritus—Gemcitabine—pancreatic cancer	0.000148	0.00111	CcSEcCtD
Fulvestrant—Infection—Docetaxel—pancreatic cancer	0.000148	0.00111	CcSEcCtD
Fulvestrant—Diarrhoea—Irinotecan—pancreatic cancer	0.000147	0.0011	CcSEcCtD
Fulvestrant—Nervous system disorder—Docetaxel—pancreatic cancer	0.000146	0.00109	CcSEcCtD
Fulvestrant—Pruritus—Fluorouracil—pancreatic cancer	0.000146	0.00109	CcSEcCtD
Fulvestrant—Infestation—Doxorubicin—pancreatic cancer	0.000146	0.00109	CcSEcCtD
Fulvestrant—Infestation NOS—Doxorubicin—pancreatic cancer	0.000146	0.00109	CcSEcCtD
Fulvestrant—Skin disorder—Docetaxel—pancreatic cancer	0.000145	0.00108	CcSEcCtD
Fulvestrant—Diarrhoea—Gemcitabine—pancreatic cancer	0.000144	0.00108	CcSEcCtD
Fulvestrant—Dizziness—Irinotecan—pancreatic cancer	0.000142	0.00107	CcSEcCtD
Fulvestrant—Haemoglobin—Epirubicin—pancreatic cancer	0.000142	0.00106	CcSEcCtD
Fulvestrant—Anorexia—Docetaxel—pancreatic cancer	0.000142	0.00106	CcSEcCtD
Fulvestrant—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000142	0.00106	CcSEcCtD
Fulvestrant—Haemorrhage—Epirubicin—pancreatic cancer	0.000141	0.00106	CcSEcCtD
Fulvestrant—Hepatitis—Epirubicin—pancreatic cancer	0.000141	0.00106	CcSEcCtD
Fulvestrant—Diarrhoea—Fluorouracil—pancreatic cancer	0.000141	0.00106	CcSEcCtD
Fulvestrant—Pharyngitis—Epirubicin—pancreatic cancer	0.00014	0.00105	CcSEcCtD
Fulvestrant—Sweating—Doxorubicin—pancreatic cancer	0.00014	0.00105	CcSEcCtD
Fulvestrant—Oedema peripheral—Epirubicin—pancreatic cancer	0.000139	0.00104	CcSEcCtD
Fulvestrant—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000139	0.00104	CcSEcCtD
Fulvestrant—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000138	0.00103	CcSEcCtD
Fulvestrant—Vomiting—Irinotecan—pancreatic cancer	0.000137	0.00103	CcSEcCtD
Fulvestrant—Dizziness—Fluorouracil—pancreatic cancer	0.000136	0.00102	CcSEcCtD
Fulvestrant—Rash—Irinotecan—pancreatic cancer	0.000136	0.00102	CcSEcCtD
Fulvestrant—Dermatitis—Irinotecan—pancreatic cancer	0.000136	0.00102	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000136	0.00102	CcSEcCtD
Fulvestrant—Headache—Irinotecan—pancreatic cancer	0.000135	0.00101	CcSEcCtD
Fulvestrant—Insomnia—Docetaxel—pancreatic cancer	0.000135	0.00101	CcSEcCtD
Fulvestrant—Paraesthesia—Docetaxel—pancreatic cancer	0.000134	0.001	CcSEcCtD
Fulvestrant—Vomiting—Gemcitabine—pancreatic cancer	0.000133	0.000999	CcSEcCtD
Fulvestrant—Dyspnoea—Docetaxel—pancreatic cancer	0.000133	0.000994	CcSEcCtD
Fulvestrant—Rash—Gemcitabine—pancreatic cancer	0.000132	0.000991	CcSEcCtD
Fulvestrant—Dermatitis—Gemcitabine—pancreatic cancer	0.000132	0.00099	CcSEcCtD
Fulvestrant—Haemoglobin—Doxorubicin—pancreatic cancer	0.000131	0.000984	CcSEcCtD
Fulvestrant—Headache—Gemcitabine—pancreatic cancer	0.000131	0.000984	CcSEcCtD
Fulvestrant—Vomiting—Fluorouracil—pancreatic cancer	0.000131	0.000982	CcSEcCtD
Fulvestrant—Dyspepsia—Docetaxel—pancreatic cancer	0.000131	0.000982	CcSEcCtD
Fulvestrant—Hepatitis—Doxorubicin—pancreatic cancer	0.000131	0.000979	CcSEcCtD
Fulvestrant—Haemorrhage—Doxorubicin—pancreatic cancer	0.000131	0.000979	CcSEcCtD
Fulvestrant—Rash—Fluorouracil—pancreatic cancer	0.00013	0.000974	CcSEcCtD
Fulvestrant—Dermatitis—Fluorouracil—pancreatic cancer	0.00013	0.000973	CcSEcCtD
Fulvestrant—Pharyngitis—Doxorubicin—pancreatic cancer	0.00013	0.000972	CcSEcCtD
Fulvestrant—Decreased appetite—Docetaxel—pancreatic cancer	0.000129	0.000969	CcSEcCtD
Fulvestrant—Headache—Fluorouracil—pancreatic cancer	0.000129	0.000968	CcSEcCtD
Fulvestrant—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000129	0.000965	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000129	0.000963	CcSEcCtD
Fulvestrant—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000129	0.000963	CcSEcCtD
Fulvestrant—Fatigue—Docetaxel—pancreatic cancer	0.000128	0.000961	CcSEcCtD
Fulvestrant—Angiopathy—Epirubicin—pancreatic cancer	0.000128	0.00096	CcSEcCtD
Fulvestrant—Nausea—Irinotecan—pancreatic cancer	0.000128	0.000958	CcSEcCtD
Fulvestrant—Immune system disorder—Epirubicin—pancreatic cancer	0.000128	0.000956	CcSEcCtD
Fulvestrant—Constipation—Docetaxel—pancreatic cancer	0.000127	0.000954	CcSEcCtD
Fulvestrant—Pain—Docetaxel—pancreatic cancer	0.000127	0.000954	CcSEcCtD
Fulvestrant—Nausea—Gemcitabine—pancreatic cancer	0.000125	0.000933	CcSEcCtD
Fulvestrant—Malnutrition—Epirubicin—pancreatic cancer	0.000123	0.000922	CcSEcCtD
Fulvestrant—Nausea—Fluorouracil—pancreatic cancer	0.000123	0.000918	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000122	0.000912	CcSEcCtD
Fulvestrant—Back pain—Epirubicin—pancreatic cancer	0.000119	0.000891	CcSEcCtD
Fulvestrant—Angiopathy—Doxorubicin—pancreatic cancer	0.000119	0.000889	CcSEcCtD
Fulvestrant—Immune system disorder—Doxorubicin—pancreatic cancer	0.000118	0.000885	CcSEcCtD
Fulvestrant—Abdominal pain—Docetaxel—pancreatic cancer	0.000118	0.000881	CcSEcCtD
Fulvestrant—Body temperature increased—Docetaxel—pancreatic cancer	0.000118	0.000881	CcSEcCtD
Fulvestrant—Malnutrition—Doxorubicin—pancreatic cancer	0.000114	0.000853	CcSEcCtD
Fulvestrant—Anaemia—Epirubicin—pancreatic cancer	0.000114	0.000852	CcSEcCtD
Fulvestrant—Vertigo—Epirubicin—pancreatic cancer	0.000111	0.000828	CcSEcCtD
Fulvestrant—Leukopenia—Epirubicin—pancreatic cancer	0.00011	0.000825	CcSEcCtD
Fulvestrant—Back pain—Doxorubicin—pancreatic cancer	0.00011	0.000825	CcSEcCtD
Fulvestrant—Hypersensitivity—Docetaxel—pancreatic cancer	0.00011	0.000822	CcSEcCtD
Fulvestrant—Cough—Epirubicin—pancreatic cancer	0.000107	0.000804	CcSEcCtD
Fulvestrant—Asthenia—Docetaxel—pancreatic cancer	0.000107	0.0008	CcSEcCtD
Fulvestrant—Pruritus—Docetaxel—pancreatic cancer	0.000105	0.000789	CcSEcCtD
Fulvestrant—Anaemia—Doxorubicin—pancreatic cancer	0.000105	0.000788	CcSEcCtD
Fulvestrant—Arthralgia—Epirubicin—pancreatic cancer	0.000105	0.000785	CcSEcCtD
Fulvestrant—Chest pain—Epirubicin—pancreatic cancer	0.000105	0.000785	CcSEcCtD
Fulvestrant—Myalgia—Epirubicin—pancreatic cancer	0.000105	0.000785	CcSEcCtD
Fulvestrant—Anxiety—Epirubicin—pancreatic cancer	0.000104	0.000782	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000104	0.000779	CcSEcCtD
Fulvestrant—Vertigo—Doxorubicin—pancreatic cancer	0.000102	0.000766	CcSEcCtD
Fulvestrant—Leukopenia—Doxorubicin—pancreatic cancer	0.000102	0.000763	CcSEcCtD
Fulvestrant—Diarrhoea—Docetaxel—pancreatic cancer	0.000102	0.000763	CcSEcCtD
Fulvestrant—Infection—Epirubicin—pancreatic cancer	9.98e-05	0.000747	CcSEcCtD
Fulvestrant—Cough—Doxorubicin—pancreatic cancer	9.94e-05	0.000744	CcSEcCtD
Fulvestrant—Nervous system disorder—Epirubicin—pancreatic cancer	9.85e-05	0.000738	CcSEcCtD
Fulvestrant—Dizziness—Docetaxel—pancreatic cancer	9.85e-05	0.000737	CcSEcCtD
Fulvestrant—Skin disorder—Epirubicin—pancreatic cancer	9.75e-05	0.000731	CcSEcCtD
Fulvestrant—Hyperhidrosis—Epirubicin—pancreatic cancer	9.71e-05	0.000727	CcSEcCtD
Fulvestrant—Chest pain—Doxorubicin—pancreatic cancer	9.69e-05	0.000726	CcSEcCtD
Fulvestrant—Myalgia—Doxorubicin—pancreatic cancer	9.69e-05	0.000726	CcSEcCtD
Fulvestrant—Arthralgia—Doxorubicin—pancreatic cancer	9.69e-05	0.000726	CcSEcCtD
Fulvestrant—Anxiety—Doxorubicin—pancreatic cancer	9.66e-05	0.000723	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	9.63e-05	0.000721	CcSEcCtD
Fulvestrant—Anorexia—Epirubicin—pancreatic cancer	9.57e-05	0.000717	CcSEcCtD
Fulvestrant—Vomiting—Docetaxel—pancreatic cancer	9.47e-05	0.000709	CcSEcCtD
Fulvestrant—Rash—Docetaxel—pancreatic cancer	9.39e-05	0.000703	CcSEcCtD
Fulvestrant—Dermatitis—Docetaxel—pancreatic cancer	9.38e-05	0.000702	CcSEcCtD
Fulvestrant—Headache—Docetaxel—pancreatic cancer	9.33e-05	0.000699	CcSEcCtD
Fulvestrant—Infection—Doxorubicin—pancreatic cancer	9.23e-05	0.000691	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	9.15e-05	0.000685	CcSEcCtD
Fulvestrant—Nervous system disorder—Doxorubicin—pancreatic cancer	9.11e-05	0.000682	CcSEcCtD
Fulvestrant—Insomnia—Epirubicin—pancreatic cancer	9.08e-05	0.00068	CcSEcCtD
Fulvestrant—Skin disorder—Doxorubicin—pancreatic cancer	9.03e-05	0.000676	CcSEcCtD
Fulvestrant—Paraesthesia—Epirubicin—pancreatic cancer	9.02e-05	0.000675	CcSEcCtD
Fulvestrant—Hyperhidrosis—Doxorubicin—pancreatic cancer	8.98e-05	0.000673	CcSEcCtD
Fulvestrant—Dyspnoea—Epirubicin—pancreatic cancer	8.95e-05	0.000671	CcSEcCtD
Fulvestrant—Anorexia—Doxorubicin—pancreatic cancer	8.86e-05	0.000663	CcSEcCtD
Fulvestrant—Nausea—Docetaxel—pancreatic cancer	8.84e-05	0.000662	CcSEcCtD
Fulvestrant—Dyspepsia—Epirubicin—pancreatic cancer	8.84e-05	0.000662	CcSEcCtD
Fulvestrant—Decreased appetite—Epirubicin—pancreatic cancer	8.73e-05	0.000654	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Epirubicin—pancreatic cancer	8.67e-05	0.000649	CcSEcCtD
Fulvestrant—Fatigue—Epirubicin—pancreatic cancer	8.66e-05	0.000648	CcSEcCtD
Fulvestrant—Pain—Epirubicin—pancreatic cancer	8.59e-05	0.000643	CcSEcCtD
Fulvestrant—Constipation—Epirubicin—pancreatic cancer	8.59e-05	0.000643	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	8.47e-05	0.000634	CcSEcCtD
Fulvestrant—Insomnia—Doxorubicin—pancreatic cancer	8.4e-05	0.000629	CcSEcCtD
Fulvestrant—Paraesthesia—Doxorubicin—pancreatic cancer	8.34e-05	0.000625	CcSEcCtD
Fulvestrant—Dyspnoea—Doxorubicin—pancreatic cancer	8.28e-05	0.00062	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Epirubicin—pancreatic cancer	8.21e-05	0.000615	CcSEcCtD
Fulvestrant—Dyspepsia—Doxorubicin—pancreatic cancer	8.18e-05	0.000613	CcSEcCtD
Fulvestrant—Decreased appetite—Doxorubicin—pancreatic cancer	8.08e-05	0.000605	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	8.02e-05	0.000601	CcSEcCtD
Fulvestrant—Fatigue—Doxorubicin—pancreatic cancer	8.01e-05	0.0006	CcSEcCtD
Fulvestrant—Urticaria—Epirubicin—pancreatic cancer	7.98e-05	0.000597	CcSEcCtD
Fulvestrant—Pain—Doxorubicin—pancreatic cancer	7.95e-05	0.000595	CcSEcCtD
Fulvestrant—Constipation—Doxorubicin—pancreatic cancer	7.95e-05	0.000595	CcSEcCtD
Fulvestrant—Body temperature increased—Epirubicin—pancreatic cancer	7.94e-05	0.000595	CcSEcCtD
Fulvestrant—Abdominal pain—Epirubicin—pancreatic cancer	7.94e-05	0.000595	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Doxorubicin—pancreatic cancer	7.6e-05	0.000569	CcSEcCtD
Fulvestrant—Hypersensitivity—Epirubicin—pancreatic cancer	7.4e-05	0.000554	CcSEcCtD
Fulvestrant—Urticaria—Doxorubicin—pancreatic cancer	7.38e-05	0.000553	CcSEcCtD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—TNF—pancreatic cancer	7.37e-05	0.00114	CbGpPWpGaD
Fulvestrant—Body temperature increased—Doxorubicin—pancreatic cancer	7.35e-05	0.00055	CcSEcCtD
Fulvestrant—Abdominal pain—Doxorubicin—pancreatic cancer	7.35e-05	0.00055	CcSEcCtD
Fulvestrant—ESR1—Signaling by ERBB4—EGF—pancreatic cancer	7.32e-05	0.00113	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	7.31e-05	0.00113	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—NOTCH4—pancreatic cancer	7.27e-05	0.00112	CbGpPWpGaD
Fulvestrant—Asthenia—Epirubicin—pancreatic cancer	7.21e-05	0.00054	CcSEcCtD
Fulvestrant—NR1H4—Generic Transcription Pathway—NOTCH1—pancreatic cancer	7.13e-05	0.0011	CbGpPWpGaD
Fulvestrant—Pruritus—Epirubicin—pancreatic cancer	7.1e-05	0.000532	CcSEcCtD
Fulvestrant—EPHX2—Metabolism—STK11—pancreatic cancer	7.08e-05	0.00109	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	7.05e-05	0.00109	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—CHD3—pancreatic cancer	7e-05	0.00108	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—MEN1—pancreatic cancer	7e-05	0.00108	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—HSPA1B—pancreatic cancer	6.94e-05	0.00107	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—RB1—pancreatic cancer	6.87e-05	0.00106	CbGpPWpGaD
Fulvestrant—Diarrhoea—Epirubicin—pancreatic cancer	6.87e-05	0.000515	CcSEcCtD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—CDH1—pancreatic cancer	6.85e-05	0.00106	CbGpPWpGaD
Fulvestrant—Hypersensitivity—Doxorubicin—pancreatic cancer	6.85e-05	0.000513	CcSEcCtD
Fulvestrant—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—pancreatic cancer	6.74e-05	0.00104	CbGpPWpGaD
Fulvestrant—NR1H4—Generic Transcription Pathway—PPARG—pancreatic cancer	6.73e-05	0.00104	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	6.73e-05	0.00104	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	6.71e-05	0.00104	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—MEN1—pancreatic cancer	6.68e-05	0.00103	CbGpPWpGaD
Fulvestrant—Asthenia—Doxorubicin—pancreatic cancer	6.67e-05	0.000499	CcSEcCtD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.64e-05	0.00103	CbGpPWpGaD
Fulvestrant—Dizziness—Epirubicin—pancreatic cancer	6.64e-05	0.000497	CcSEcCtD
Fulvestrant—ESR1—Generic Transcription Pathway—NOTCH4—pancreatic cancer	6.63e-05	0.00102	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	6.58e-05	0.00102	CbGpPWpGaD
Fulvestrant—Pruritus—Doxorubicin—pancreatic cancer	6.57e-05	0.000492	CcSEcCtD
Fulvestrant—ESR1—Signaling by ERBB4—PIK3CD—pancreatic cancer	6.51e-05	0.001	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	6.5e-05	0.001	CbGpPWpGaD
Fulvestrant—Vomiting—Epirubicin—pancreatic cancer	6.39e-05	0.000478	CcSEcCtD
Fulvestrant—ESRRA—Gene Expression—SMAD4—pancreatic cancer	6.37e-05	0.000983	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	6.37e-05	0.000982	CbGpPWpGaD
Fulvestrant—Diarrhoea—Doxorubicin—pancreatic cancer	6.36e-05	0.000476	CcSEcCtD
Fulvestrant—NR1H4—Metabolism—GLP1R—pancreatic cancer	6.35e-05	0.000979	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—NOTCH4—pancreatic cancer	6.33e-05	0.000977	CbGpPWpGaD
Fulvestrant—Rash—Epirubicin—pancreatic cancer	6.33e-05	0.000474	CcSEcCtD
Fulvestrant—Dermatitis—Epirubicin—pancreatic cancer	6.33e-05	0.000474	CcSEcCtD
Fulvestrant—NR1H4—Gene Expression—EZH2—pancreatic cancer	6.32e-05	0.000975	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GDI1—pancreatic cancer	6.3e-05	0.000971	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GDI2—pancreatic cancer	6.3e-05	0.000971	CbGpPWpGaD
Fulvestrant—Headache—Epirubicin—pancreatic cancer	6.29e-05	0.000471	CcSEcCtD
Fulvestrant—ESRRA—Metabolism—CD44—pancreatic cancer	6.28e-05	0.000969	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	6.27e-05	0.000967	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—DPYD—pancreatic cancer	6.24e-05	0.000963	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—TP53—pancreatic cancer	6.22e-05	0.00096	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	6.22e-05	0.000959	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—NOTCH1—pancreatic cancer	6.21e-05	0.000958	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—NOTCH3—pancreatic cancer	6.18e-05	0.000954	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.15e-05	0.000948	CbGpPWpGaD
Fulvestrant—Dizziness—Doxorubicin—pancreatic cancer	6.14e-05	0.00046	CcSEcCtD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	6.09e-05	0.00094	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	6.09e-05	0.00094	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—TYMS—pancreatic cancer	6.09e-05	0.000939	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—HSPA1B—pancreatic cancer	6.04e-05	0.000932	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—GCG—pancreatic cancer	6.02e-05	0.000929	CbGpPWpGaD
Fulvestrant—Nausea—Epirubicin—pancreatic cancer	5.97e-05	0.000447	CcSEcCtD
Fulvestrant—NR1H4—Metabolism—SLC2A2—pancreatic cancer	5.92e-05	0.000914	CbGpPWpGaD
Fulvestrant—Vomiting—Doxorubicin—pancreatic cancer	5.91e-05	0.000442	CcSEcCtD
Fulvestrant—ESR1—Gene Expression—NR5A2—pancreatic cancer	5.87e-05	0.000905	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	5.86e-05	0.000905	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—PPARG—pancreatic cancer	5.86e-05	0.000904	CbGpPWpGaD
Fulvestrant—Rash—Doxorubicin—pancreatic cancer	5.86e-05	0.000439	CcSEcCtD
Fulvestrant—NR1H4—Gene Expression—HSPA1A—pancreatic cancer	5.86e-05	0.000904	CbGpPWpGaD
Fulvestrant—Dermatitis—Doxorubicin—pancreatic cancer	5.85e-05	0.000438	CcSEcCtD
Fulvestrant—Headache—Doxorubicin—pancreatic cancer	5.82e-05	0.000436	CcSEcCtD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	5.71e-05	0.000881	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—PIK3CB—pancreatic cancer	5.67e-05	0.000875	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—STK11—pancreatic cancer	5.66e-05	0.000873	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	5.66e-05	0.000873	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—NOTCH3—pancreatic cancer	5.64e-05	0.00087	CbGpPWpGaD
Fulvestrant—ESR1—Leptin signaling pathway—HRAS—pancreatic cancer	5.63e-05	0.000868	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	5.52e-05	0.000852	CbGpPWpGaD
Fulvestrant—Nausea—Doxorubicin—pancreatic cancer	5.52e-05	0.000413	CcSEcCtD
Fulvestrant—ESR2—Gene Expression—EZH2—pancreatic cancer	5.5e-05	0.000849	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—NOTCH3—pancreatic cancer	5.39e-05	0.000831	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of Telomerase—AKT1—pancreatic cancer	5.37e-05	0.000829	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.31e-05	0.00082	CbGpPWpGaD
Fulvestrant—ESRRA—Generic Transcription Pathway—MYC—pancreatic cancer	5.25e-05	0.00081	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—CASP3—pancreatic cancer	5.24e-05	0.000809	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.15e-05	0.000795	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—CCND1—pancreatic cancer	5.1e-05	0.000788	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—HSPA1A—pancreatic cancer	5.1e-05	0.000787	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—CTNNB1—pancreatic cancer	5.05e-05	0.00078	CbGpPWpGaD
Fulvestrant—ESR1—Leptin signaling pathway—AKT1—pancreatic cancer	4.97e-05	0.000767	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—APOE—pancreatic cancer	4.95e-05	0.000764	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—PTEN—pancreatic cancer	4.93e-05	0.00076	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—PTEN—pancreatic cancer	4.9e-05	0.000756	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—TYMS—pancreatic cancer	4.87e-05	0.000751	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—NOTCH1—pancreatic cancer	4.7e-05	0.000725	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.69e-05	0.000723	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	4.68e-05	0.000722	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—pancreatic cancer	4.67e-05	0.000721	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	4.67e-05	0.00072	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—SMAD4—pancreatic cancer	4.66e-05	0.000719	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CD44—pancreatic cancer	4.59e-05	0.000708	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.49e-05	0.000693	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PIK3CG—pancreatic cancer	4.47e-05	0.00069	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.45e-05	0.000687	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—VEGFA—pancreatic cancer	4.45e-05	0.000687	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—PPARG—pancreatic cancer	4.43e-05	0.000684	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GCG—pancreatic cancer	4.4e-05	0.000679	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—NRAS—pancreatic cancer	4.37e-05	0.000675	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	4.34e-05	0.00067	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PPARG—pancreatic cancer	4.31e-05	0.000666	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—SMAD4—pancreatic cancer	4.25e-05	0.000656	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	4.23e-05	0.000653	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	4.19e-05	0.000646	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—STK11—pancreatic cancer	4.14e-05	0.000638	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—MYC—pancreatic cancer	4.09e-05	0.000632	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	4.08e-05	0.00063	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PRLHR—pancreatic cancer	4.06e-05	0.000626	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—SMAD4—pancreatic cancer	4.06e-05	0.000626	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—EGFR—pancreatic cancer	4e-05	0.000618	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—EGFR—pancreatic cancer	3.98e-05	0.000615	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—APOE—pancreatic cancer	3.96e-05	0.000611	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PIK3CD—pancreatic cancer	3.93e-05	0.000606	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.88e-05	0.000599	CbGpPWpGaD
Fulvestrant—NR1H4—Generic Transcription Pathway—MYC—pancreatic cancer	3.84e-05	0.000592	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ZNRF3—pancreatic cancer	3.81e-05	0.000588	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ACVR1B—pancreatic cancer	3.81e-05	0.000588	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	3.79e-05	0.000584	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—KRAS—pancreatic cancer	3.78e-05	0.000584	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—KRAS—pancreatic cancer	3.76e-05	0.000581	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.75e-05	0.000578	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	3.69e-05	0.000569	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PIK3CG—pancreatic cancer	3.57e-05	0.000551	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—TYMS—pancreatic cancer	3.56e-05	0.000549	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—PIK3CA—pancreatic cancer	3.46e-05	0.000533	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SSTR3—pancreatic cancer	3.45e-05	0.000532	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—DTX1—pancreatic cancer	3.45e-05	0.000532	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PPARG—pancreatic cancer	3.45e-05	0.000532	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—NOTCH1—pancreatic cancer	3.43e-05	0.00053	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PIK3CB—pancreatic cancer	3.42e-05	0.000528	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PTGS2—pancreatic cancer	3.39e-05	0.000524	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	3.39e-05	0.000523	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	3.38e-05	0.000522	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—MEN1—pancreatic cancer	3.37e-05	0.00052	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—TP53—pancreatic cancer	3.36e-05	0.000519	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—MYC—pancreatic cancer	3.34e-05	0.000516	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	3.32e-05	0.000512	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SSTR1—pancreatic cancer	3.31e-05	0.00051	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PPY—pancreatic cancer	3.24e-05	0.0005	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—PPARG—pancreatic cancer	3.24e-05	0.0005	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—HRAS—pancreatic cancer	3.2e-05	0.000494	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—NOTCH4—pancreatic cancer	3.19e-05	0.000493	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SSTR2—pancreatic cancer	3.18e-05	0.000491	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	3.16e-05	0.000488	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PIK3CD—pancreatic cancer	3.14e-05	0.000485	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	3.13e-05	0.000484	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—NOTCH1—pancreatic cancer	3.13e-05	0.000483	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCKBR—pancreatic cancer	3.07e-05	0.000474	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—HSPA1B—pancreatic cancer	3.05e-05	0.00047	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—NOTCH1—pancreatic cancer	2.99e-05	0.000461	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PTEN—pancreatic cancer	2.96e-05	0.000457	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—PPARG—pancreatic cancer	2.96e-05	0.000456	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—APOE—pancreatic cancer	2.89e-05	0.000446	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—DTX4—pancreatic cancer	2.89e-05	0.000446	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GLI1—pancreatic cancer	2.89e-05	0.000446	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	2.88e-05	0.000444	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—AKT1—pancreatic cancer	2.84e-05	0.000438	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—AKT1—pancreatic cancer	2.82e-05	0.000436	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—PPARG—pancreatic cancer	2.82e-05	0.000435	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NRP1—pancreatic cancer	2.81e-05	0.000434	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PPP2R5B—pancreatic cancer	2.81e-05	0.000434	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	2.79e-05	0.00043	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—EZH2—pancreatic cancer	2.77e-05	0.000428	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.74e-05	0.000423	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PIK3CB—pancreatic cancer	2.74e-05	0.000422	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—NOTCH3—pancreatic cancer	2.72e-05	0.000419	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PTGS2—pancreatic cancer	2.71e-05	0.000419	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HEY2—pancreatic cancer	2.71e-05	0.000418	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GAST—pancreatic cancer	2.64e-05	0.000408	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PIK3CG—pancreatic cancer	2.61e-05	0.000403	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—HSPA1A—pancreatic cancer	2.57e-05	0.000397	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—MYC—pancreatic cancer	2.53e-05	0.00039	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PPARG—pancreatic cancer	2.52e-05	0.000389	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SCT—pancreatic cancer	2.51e-05	0.000387	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HEY1—pancreatic cancer	2.51e-05	0.000387	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCK—pancreatic cancer	2.39e-05	0.000369	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PTEN—pancreatic cancer	2.37e-05	0.000365	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	2.35e-05	0.000363	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CNR2—pancreatic cancer	2.33e-05	0.000359	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GLP1R—pancreatic cancer	2.33e-05	0.000359	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PIK3CD—pancreatic cancer	2.3e-05	0.000354	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCKAR—pancreatic cancer	2.29e-05	0.000354	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—JAG2—pancreatic cancer	2.22e-05	0.000343	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MEN1—pancreatic cancer	2.19e-05	0.000338	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SHH—pancreatic cancer	2.09e-05	0.000322	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PIK3CA—pancreatic cancer	2.09e-05	0.000322	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NOTCH4—pancreatic cancer	2.08e-05	0.00032	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IAPP—pancreatic cancer	2.06e-05	0.000318	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—SMAD4—pancreatic cancer	2.05e-05	0.000316	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PIK3CB—pancreatic cancer	2e-05	0.000309	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PTGS2—pancreatic cancer	1.98e-05	0.000306	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PTHLH—pancreatic cancer	1.98e-05	0.000306	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PTCH1—pancreatic cancer	1.98e-05	0.000306	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—MYC—pancreatic cancer	1.85e-05	0.000285	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SST—pancreatic cancer	1.81e-05	0.00028	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—JAG1—pancreatic cancer	1.77e-05	0.000274	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NOTCH3—pancreatic cancer	1.77e-05	0.000272	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—AKT1—pancreatic cancer	1.75e-05	0.000271	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PTEN—pancreatic cancer	1.73e-05	0.000267	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—AKT1—pancreatic cancer	1.71e-05	0.000263	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—MYC—pancreatic cancer	1.69e-05	0.00026	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CNR1—pancreatic cancer	1.67e-05	0.000258	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PIK3CA—pancreatic cancer	1.67e-05	0.000258	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GCG—pancreatic cancer	1.61e-05	0.000249	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—MYC—pancreatic cancer	1.61e-05	0.000248	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AGTR1—pancreatic cancer	1.54e-05	0.000238	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—STK11—pancreatic cancer	1.52e-05	0.000234	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—NOTCH1—pancreatic cancer	1.51e-05	0.000233	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.49e-05	0.000229	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—PPARG—pancreatic cancer	1.42e-05	0.00022	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—AKT1—pancreatic cancer	1.36e-05	0.00021	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SMAD4—pancreatic cancer	1.33e-05	0.000205	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HES1—pancreatic cancer	1.3e-05	0.0002	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.29e-05	0.000199	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—AKT1—pancreatic cancer	1.28e-05	0.000198	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PIK3CA—pancreatic cancer	1.22e-05	0.000188	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TERT—pancreatic cancer	1.14e-05	0.000176	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.13e-05	0.000174	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—AKT1—pancreatic cancer	1.12e-05	0.000172	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HIF1A—pancreatic cancer	1.09e-05	0.000168	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TSC2—pancreatic cancer	1.09e-05	0.000167	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—APOE—pancreatic cancer	1.06e-05	0.000164	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—KDR—pancreatic cancer	1.04e-05	0.000161	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—AKT1—pancreatic cancer	9.96e-06	0.000154	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NFKBIA—pancreatic cancer	9.9e-06	0.000153	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NOTCH1—pancreatic cancer	9.8e-06	0.000151	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PIK3CG—pancreatic cancer	9.59e-06	0.000148	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—EGF—pancreatic cancer	9.48e-06	0.000146	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GLP1R—pancreatic cancer	9.08e-06	0.00014	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—DPYD—pancreatic cancer	8.94e-06	0.000138	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	8.48e-06	0.000131	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PIK3CD—pancreatic cancer	8.43e-06	0.00013	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—MYC—pancreatic cancer	8.11e-06	0.000125	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PIK3CB—pancreatic cancer	7.35e-06	0.000113	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CXCL8—pancreatic cancer	7.06e-06	0.000109	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CASP3—pancreatic cancer	6.76e-06	0.000104	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCND1—pancreatic cancer	6.58e-06	0.000101	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CD44—pancreatic cancer	6.57e-06	0.000101	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CTNNB1—pancreatic cancer	6.51e-06	0.0001	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MMP9—pancreatic cancer	6.38e-06	9.85e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PTEN—pancreatic cancer	6.35e-06	9.79e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GCG—pancreatic cancer	6.3e-06	9.71e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—STK11—pancreatic cancer	5.92e-06	9.13e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SRC—pancreatic cancer	5.89e-06	9.08e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—VEGFA—pancreatic cancer	5.73e-06	8.85e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—STAT3—pancreatic cancer	5.68e-06	8.76e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NRAS—pancreatic cancer	5.66e-06	8.74e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—AKT1—pancreatic cancer	5.63e-06	8.68e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MYC—pancreatic cancer	5.27e-06	8.14e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TGFB1—pancreatic cancer	5.26e-06	8.12e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—EGFR—pancreatic cancer	5.16e-06	7.96e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—TYMS—pancreatic cancer	5.09e-06	7.86e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—KRAS—pancreatic cancer	4.87e-06	7.52e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PIK3CA—pancreatic cancer	4.48e-06	6.91e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TP53—pancreatic cancer	4.33e-06	6.68e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HRAS—pancreatic cancer	4.14e-06	6.39e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—APOE—pancreatic cancer	4.14e-06	6.39e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	3.74e-06	5.77e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AKT1—pancreatic cancer	3.66e-06	5.64e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PPARG—pancreatic cancer	3.61e-06	5.57e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	3.29e-06	5.07e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	2.86e-06	4.42e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PTGS2—pancreatic cancer	2.84e-06	4.38e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PTEN—pancreatic cancer	2.47e-06	3.82e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.75e-06	2.69e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.43e-06	2.2e-05	CbGpPWpGaD
